Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index; 1 of the 9 sources its claims cite were checked for support.
Abstract
BACKGROUND: The severe acute respiratory syndrome (SARS) has recently been identified as a new clinical entity. SARS is thought to be caused by an unknown infectious agent. METHODS: Clinical specimens from patients with SARS were searched for unknown viruses with the use of cell cultures and molecular techniques. RESULTS: A novel coronavirus was identified in patients with SARS. The virus was isolated in cell culture, and a sequence 300 nucleotides in length was obtained by a polymerase-chain-reaction (PCR)-based random-amplification procedure. Genetic characterization indicated that the virus is only distantly related to known coronaviruses (identical in 50 to 60 percent of the nucleotide sequence). On the basis of the obtained sequence, conventional and real-time PCR assays for specific and sensitive detection of the novel virus were established. Virus was detected in a variety of clinical specimens from patients with SARS but not in controls. High concentrations of viral RNA of up to 100 million molecules per milliliter were found in sputum. Viral RNA was also detected at extremely low concentrations in plasma during the acute phase and in feces during the late convalescent phase. Infected patients showed seroconversion on the Vero cells in which the virus was isolated. CONCLUSIONS: The novel coronavirus might have a role in causing SARS.
Overview
CoChat Summary
## TL;DR
The paper identifies a previously unknown coronavirus in patients with severe acute respiratory syndrome (SARS) and provides PCR and serologic evidence linking it to the illness. It also reports that viral RNA was found at very high levels in sputum, with lower-level detection in plasma and later in stool, supporting a respiratory infection with possible additional shedding routes.
## Key findings
- A novel coronavirus was isolated from sputum of the index patient after 6 days of incubation in Vero-cell culture, and a 300-nucleotide sequence was obtained by random RT-PCR.
- Genetic analysis found the virus was only distantly related to known coronaviruses, with the BNI-1 sequence differing by 39% to 46% from known sequences and by 50% to 60% identical nucleotide sequence to known coronaviruses.
- In the Hanoi outbreak panel, the virus was detected in 100% of patients with probable SARS, 23% of those with suspected SARS, and 0% of healthy contacts.
- Quantitative PCR found viral RNA concentrations of up to 100 million molecules per milliliter in sputum; the index patient also had RNA in plasma at 190 (day 9) and stool on day 25, and Contact 1 had 6.3 × 10^4 in sputum and 4.1 × 10^5 in BAL.
## Methods
- Clinical specimens from SARS patients were screened for known and unknown pathogens using cell culture, electron microscopy, PCR, antigen ELISA, serology, and sequence/phylogenetic analysis.
- The study examined specimens from 3 patients in Frankfurt (index patient, Contact 1, Contact 2) and a panel of 49 specimens from 18 suspected/probable SARS patients and 21 healthy contacts in Hanoi, plus 54 stool controls from Germany.
- A random RT-PCR approach and subsequent nested and real-time RT-PCR assays were developed to identify and quantify the novel virus, with specificity tested against several other coronaviruses.
## Limitations
- The paper itself states that larger studies with appropriate control groups are needed to verify or reject the hypothesis that this virus causes SARS.
- The authors note that the antibody response might not be definitively directed against the novel coronavirus, because the antigen used in serology came from primary cultures; they say this should be tested with plaque-purified virus or recombinant proteins.
- Evidence of causation is not established here; the paper shows association and detection in patients, but the conclusion is only that the virus “might have a role” in causing SARS.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 Valid · 0 Not valid · 7 Not checked · 67 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The presence of viral RNA in stool of the patients late during convalescence is reminiscent of characteristics of other coronaviruses. 13”
What the sources say
- Partly supportedcites [13] matched to “Evaluation of concurrent shedding of bovine coronavirus via the respiratory tract and enteric route in feedlot cattle” (2001) sourceExperimental — accuracy not yet measured
Our copy of Cho et al (2001) supports only the general point that a bovine coronavirus is present/shed in feces: fecal samples from 56 feedlot steers were positive for BCV by antigen-capture ELISA and virus isolation (Results, p. 1; Materials and Methods, Sample Collections), and the Discussion (p. 6) notes 22% of fecal samples from cattle without diarrhea were antigen-positive, suggesting they 'had diarrhea during shipping or at the auction barn and were still shedding BCV'. The specific elements the citing sentence attributes are absent: detection was of antigen/infectious virus, not viral RNA (no RT-PCR assay appears anywhere in our copy; RT-PCR of feces belongs to a work it cites, Tsunemitsu and Saif, ref 35), samples were taken only on days 0, 4, 14 and 21 after arrival rather than late during convalescence, in cattle rather than human patients, and the paper makes no comparative statement about shared characteristics of other coronaviruses. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Infected patients showed seroconversion on the Vero cells in which the virus was isolated.”
- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“About 20 distinct DNA fragments were obtained and sequenced.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Three of the fragments did not match any nucleotide sequence in the data base.”
plainSingle case- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“since there was serologic evidence of an acute infection with this virus in our index patient and also in Contact 1”
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims
Create a free account to see all 75 claims and to verify the 7 references still open.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 11
Citations
Cites
PHYLIP-Phylogeny inference package (Version 3.2)
Felsenstein, J. (1989) · Cladistics · Cited by 17,682
Identification of Severe Acute Respiratory Syndrome in Canada
Poutanen, S. M., Low, D. E., Henry, B., Finkelstein, S., Rose, D., Green, K., Tellier, R., Draker, R., Adachi, D., Ayers, M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030634 · Cited by 1,132
A Cluster of Cases of Severe Acute Respiratory Syndrome in Hong Kong
Tsang, K. W., Ho, P. L., Ooi, G. C., Yee, W. K., Wang, T., Chan-Yeung, M., Lam, W. K., Seto, W. H., Yam, L. Y., Cheung, T. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030666 · Cited by 1,017
Viruses and bacteria in the etiology of the common cold
Mäkelä, M. J., Puhakka, T., Ruuskanen, O., Leinonen, M., Saikku, P., Kimpimäki, M., Blomqvist, S., Hyypiä, T., & Arstila, P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.539-542.1998 · Cited by 768
Drosten, C., Göttig, S., Schilling, S., Asper, M., Panning, M., Schmitz, H., & Günther, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2323-2330.2002 · Cited by 631
Self-citationImported Lassa Fever in Germany: Molecular Characterization of a New Lassa Virus Strain
Günther, S., Emmerich, P., Laue, T., Kühle, O., Asper, M., Jung, A., Grewing, T., ter Meulen, J., & Schmitz, H. (2000) · Emerging Infectious Diseases · doi:10.3201/eid0605.000504 · Cited by 200
Self-citationStephensen, C. B., Casebolt, D. B., & Gangopadhyay, N. N. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00017-9 · Cited by 135
Cho, K.-O., Hoet, A. E., Loerch, S. C., Wittum, T. E., & Saif, L. J. (2001) · American Journal of Veterinary Research · doi:10.2460/ajvr.2001.62.1436 · Cited by 88
TTV a common virus, but pathogenic?
Cossart, Y. E. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77802-8 · Cited by 44
HGV: hepatitis G virus or harmless G virus?
Kew, M. C., & Kassianides, C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)98020-4 · Cited by 39
Research works printed but not linked: 2
- 2003, Wkly Epidemiol Rec, 78, 81
- 2003, Wkly Epidemiol Rec, 78, 73
Cited by
Items 201–300 of 1,020
Chan, K., Lai, S. T., Chu, C., Tsui, E. L. H., Tam, C. Y., Wong, M. M.-L., Tse, M. W., Que, T. L., Peiris, M. J. S., Sung, J. J. �., et al. (2003) · PubMed · Cited by 473
Global patterns in coronavirus diversity
Anthony, S. J., Johnson, C. K., Greig, D. J., Kramer, S., Che, X., Wells, H., Hicks, A. L., Joly, D. O., Wolfe, N. D., Daszak, P., et al. (2017) · Virus Evolution · doi:10.1093/ve/vex012 · Cited by 427
SARS-associated viral hepatitis caused by a novel coronavirus: Report of three cases
Chau, T.-N., Lee, K.-C., Yao, H., Tsang, T.-Y., Chow, T.-C., Yeung, Y.-C., Choi, K.-W., Tso, Y.-K., Lau, T., Lai, S.-T., et al. (2004) · Hepatology · doi:10.1002/hep.20111 · Cited by 424
Narayanan, K., Huang, C., Lokugamage, K., Kamitani, W., Ikegami, T., Tseng, C.-T. K., & Makino, S. (2008) · Journal of Virology · doi:10.1128/jvi.02472-07 · Cited by 427
Orchitis: A Complication of Severe Acute Respiratory Syndrome (SARS)1
Xu, J., Qi, L., Chi, X., Yang, J., Wei, X., Gong, E., Peh, S., & Gu, J. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.105.044776 · Cited by 418
Antiviral Activity of Glycyrrhizic Acid Derivatives against SARS−Coronavirus
Hoever, G., Baltina, L., Michaelis, M., Kondratenko, R., Baltina, L., Tolstikov, G. A., Doerr, H. W., & Cinatl, J. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0493008 · Cited by 416
Self-citationSARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
Totura, A. L., & Baric, R. S. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.04.004 · Cited by 415
Bisht, H., Roberts, A., Vogel, L., Bukreyev, A., Collins, P. L., Murphy, B. R., Subbarao, K., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401939101 · Cited by 420
Sim, K., Huak Chan, Y., Chong, P. N., Chua, H. C., & Wen Soon, S. (2010) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.04.004 · Cited by 414
“This potentially fatal condition was reported to be caused by the SARS-associated coronavirus and is characterised by both an atypical pneumonia and efficient droplet transmission [18].”
BackgroundInhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs
SHI, Y., YANG, D. H., XIONG, J., JIA, J., HUANG, B., & JIN, Y. X. (2005) · Cell Research · doi:10.1038/sj.cr.7290286 · Cited by 414
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Gu, S. X., Tyagi, T., Jain, K., Gu, V. W., Lee, S. H., Hwa, J. M., Kwan, J. M., Krause, D. S., Lee, A. I., Halene, S., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00469-1 · Cited by 418
Franks, T. J., Chong, P. Y., Chui, P., Galvin, J. R., Lourens, R. M., Reid, A. H., Selbs, E., Mcevoy, C. P. L., Hayden, C. D. L., Fukuoka, J., et al. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00367-8 · Cited by 415
Age- and gender-related difference of ACE2 expression in rat lung
Xudong, X., Junzhu, C., Xingxiang, W., Furong, Z., & Yanrong, L. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.09.038 · Cited by 410
“SARS-CoV spreads mainly via the respiratory route (Ksiazek et al., 2003; Drosten et al., 2003; Fouchier et al., 2003) , and the lungs are the main targets (Ding et al., 2003) .”
Genetic Screens Identify Host Factors for SARS-CoV-2 and Common Cold Coronaviruses
Wang, R., Simoneau, C. R., Kulsuptrakul, J., Bouhaddou, M., Travisano, K. A., Hayashi, J. M., Carlson-Stevermer, J., Zengel, J. R., Richards, C. M., Fozouni, P., et al. (2021) · Cell · doi:10.1016/j.cell.2020.12.004 · Cited by 414
El Zowalaty, M. E., & Järhult, J. D. (2020) · One Health · doi:10.1016/j.onehlt.2020.100124 · Cited by 405
Are pangolins the intermediate host of the 2019 novel coronavirus (SARS-CoV-2)?
Liu, P., Jiang, J.-Z., Wan, X.-F., Hua, Y., Li, L., Zhou, J., Wang, X., Hou, F., Chen, J., Zou, J., et al. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008421 · Cited by 410
Kamitani, W., Narayanan, K., Huang, C., Lokugamage, K., Ikegami, T., Ito, N., Kubo, H., & Makino, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603144103 · Cited by 416
The Nucleocapsid Protein of SARS–CoV-2: a Target for Vaccine Development
Dutta, N. K., Mazumdar, K., & Gordy, J. T. (2020) · Journal of Virology · doi:10.1128/jvi.00647-20 · Cited by 410
Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS
Drexler, J. F., Corman, V. M., & Drosten, C. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2013.10.013 · Cited by 406
Self-citationZhao, Z. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05320-0 · Cited by 407
Survival of surrogate coronaviruses in water
Casanova, L., Rutala, W. A., Weber, D. J., & Sobsey, M. D. (2009) · Water Research · doi:10.1016/j.watres.2009.02.002 · Cited by 405
Serological assays for emerging coronaviruses: Challenges and pitfalls
Meyer, B., Drosten, C., & Müller, M. A. (2014) · Virus Research · doi:10.1016/j.virusres.2014.03.018 · Cited by 410
Self-citationMaunder, R. (2004) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2004.1483 · Cited by 403
Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China
Ye, M., Fu, D., Ren, Y., Wang, F., Wang, D., Zhang, F., Xia, X., & Lv, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25882 · Cited by 410
Wang, C., Xie, J., Zhao, L., Fei, X., Zhang, H., Tan, Y., Nie, X., Zhou, L., Liu, Z., Ren, Y., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102833 · Cited by 412
Gemmati, D., Bramanti, B., Serino, M. L., Secchiero, P., Zauli, G., & Tisato, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103474 · Cited by 395
A review of studies on animal reservoirs of the SARS coronavirus
Shi, Z., & Hu, Z. (2008) · Virus Research · doi:10.1016/j.virusres.2007.03.012 · Cited by 400
Ultrastructural Characterization of SARS Coronavirus
Goldsmith, C. S., Tatti, K. M., Ksiazek, T. G., Rollin, P. E., Comer, J. A., Lee, W. W., Rota, P. A., Bankamp, B., Bellini, W. J., & Zaki, S. R. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030913 · Cited by 405
He, Y., Zhou, Y., Liu, S., Kou, Z., Li, W., Farzan, M., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.106 · Cited by 403
Chen, J., Lau, Y. F., Lamirande, E. W., Paddock, C. D., Bartlett, J. H., Zaki, S. R., & Subbarao, K. (2010) · Journal of Virology · doi:10.1128/jvi.01281-09 · Cited by 399
Subbarao, K., McAuliffe, J., Vogel, L., Fahle, G., Fischer, S., Tatti, K., Packard, M., Shieh, W.-J., Zaki, S., & Murphy, B. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3572-3577.2004 · Cited by 406
Modelling strategies for controlling SARS outbreaks
Gumel, A. B., Ruan, S., Day, T., Watmough, J., Brauer, F., van den Driessche, P., Gabrielson, D., Bowman, C., Alexander, M. E., Ardal, S., et al. (2004) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.2004.2800 · Cited by 397
Association between a Novel Human Coronavirus and Kawasaki Disease
Esper, F., Shapiro, E. D., Weibel, C., Ferguson, D., Landry, M. L., & Kahn, J. S. (2005) · The Journal of Infectious Diseases · doi:10.1086/428291 · Cited by 397
Drexler, J. F., Gloza-Rausch, F., Glende, J., Corman, V. M., Muth, D., Goettsche, M., Seebens, A., Niedrig, M., Pfefferle, S., Yordanov, S., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00650-10 · Cited by 392
Self-citationTransmission of MERS-Coronavirus in Household Contacts
Drosten, C., Meyer, B., Müller, M. A., Corman, V. M., Al-Masri, M., Hossain, R., Madani, H., Sieberg, A., Bosch, B. J., Lattwein, E., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1405858 · Cited by 393
Self-citationChan, J. W. M. (2003) · Thorax · doi:10.1136/thorax.58.8.686 · Cited by 394
Outcomes and Prognostic Factors in 267 Patients with Severe Acute Respiratory Syndrome in Hong Kong
Choi, K. W., Chau, T. N., Tsang, O., Tso, E., Chiu, M. C., Tong, W. L., Lee, P. O., Ng, T. K., Ng, W. F., Lee, K. C., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-9-200311040-00005 · Cited by 397
Lancee, W. J., Maunder, R. G., & Goldbloom, D. S. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.1.91 · Cited by 391
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu, L., Liu, Q., Zhu, Y., Chan, K.-H., Qin, L., Li, Y., Wang, Q., Chan, J. F.-W., Du, L., Yu, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms4067 · Cited by 388
Opportunities and Challenges for Biosensors and Nanoscale Analytical Tools for Pandemics: COVID-19
Bhalla, N., Pan, Y., Yang, Z., & Payam, A. F. (2020) · ACS Nano · doi:10.1021/acsnano.0c04421 · Cited by 385
CKD of Unknown Origin in Central America: The Case for a Mesoamerican Nephropathy
Correa-Rotter, R., Wesseling, C., & Johnson, R. J. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.10.062 · Cited by 383
Drosten, C., Seilmaier, M., Corman, V. M., Hartmann, W., Scheible, G., Sack, S., Guggemos, W., Kallies, R., Muth, D., Junglen, S., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70154-3 · Cited by 387
Self-citationSoo, Y. O. Y., Cheng, Y., Wong, R., Hui, D. S., Lee, C. K., Tsang, K. K. S., Ng, M. H. L., Chan, P., Cheng, G., & Sung, J. J. Y. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.00956.x · Cited by 381
Westhaus, S., Weber, F.-A., Schiwy, S., Linnemann, V., Brinkmann, M., Widera, M., Greve, C., Janke, A., Hollert, H., Wintgens, T., et al. (2021) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141750 · Cited by 381
Coronaviruses and SARS-CoV-2: A Brief Overview
Ludwig, S., & Zarbock, A. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004845 · Cited by 376
Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques
Haagmans, B. L., Kuiken, T., Martina, B. E., Fouchier, R. A. M., Rimmelzwaan, G. F., van Amerongen, G., van Riel, D., de Jong, T., Itamura, S., Chan, K.-H., et al. (2004) · Nature Medicine · doi:10.1038/nm1001 · Cited by 381
Self-citationKratzel, A., Todt, D., V’kovski, P., Steiner, S., Gultom, M., Thao, T. T. N., Ebert, N., Holwerda, M., Steinmann, J., Niemeyer, D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200915 · Cited by 375
Self-citationThe intracellular sites of early replication and budding of SARS-coronavirus
Stertz, S., Reichelt, M., Spiegel, M., Kuri, T., Martínez-Sobrido, L., García-Sastre, A., Weber, F., & Kochs, G. (2007) · Virology · doi:10.1016/j.virol.2006.11.027 · Cited by 382
Varia, M., Wilson, S., Sarwal, S., McGeer, A., Gournis, E., Galanis, E., & Henry, B. (2003) · PubMed · Cited by 426
Huang, I.-C., Bosch, B. J., Li, F., Li, W., Lee, K. H., Ghiran, S., Vasilieva, N., Dermody, T. S., Harrison, S. C., Dormitzer, P. R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508381200 · Cited by 375
COVID-19: Virology, biology and novel laboratory diagnosis
Mohamadian, M., Chiti, H., Shoghli, A., Biglari, S., Parsamanesh, N., & Esmaeilzadeh, A. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3303 · Cited by 371
Human Betacoronavirus 2c EMC/2012–related Viruses in Bats, Ghana and Europe
Annan, A., Baldwin, H. J., Corman, V. M., Klose, S. M., Owusu, M., Nkrumah, E. E., Badu, E. K., Anti, P., Agbenyega, O., Meyer, B., et al. (2013) · Emerging Infectious Diseases · doi:10.3201/eid1903.121503 · Cited by 376
Self-citationAntivirals and antiviral strategies
Clercq, E. D. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro975 · Cited by 370
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus
Yount, B., Curtis, K. M., Fritz, E. A., Hensley, L. E., Jahrling, P. B., Prentice, E., Denison, M. R., Geisbert, T. W., & Baric, R. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1735582100 · Cited by 376
Frieman, M., Ratia, K., Johnston, R. E., Mesecar, A. D., & Baric, R. S. (2009) · Journal of Virology · doi:10.1128/jvi.02220-08 · Cited by 368
He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 366
Ocular Tropism of Respiratory Viruses
Belser, J. A., Rota, P. A., & Tumpey, T. M. (2013) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00058-12 · Cited by 360
Alimohamadi, Y., Sepandi, M., Taghdir, M., & Hosamirudsari, H. (2020) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2020.61.3.1530 · Cited by 345
RETRACTED ARTICLE: Origin and cross-species transmission of bat coronaviruses in China
Latinne, A., Hu, B., Olival, K. J., Zhu, G., Zhang, L., Li, H., Chmura, A. A., Field, H. E., Zambrana-Torrelio, C., Epstein, J. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17687-3 · Cited by 339
RetractedMuralidar, S., Ambi, S. V., Sekaran, S., & Krishnan, U. M. (2020) · Biochimie · doi:10.1016/j.biochi.2020.09.018 · Cited by 346
Epidemiology of Human Metapneumovirus
Kahn, J. S. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00014-06 · Cited by 355
Real-Time Reverse Transcription–Polymerase Chain Reaction Assay for SARS-associated Coronavirus
Emery, S. L., Erdman, D. D., Bowen, M. D., Newton, B. R., Winchell, J. M., Meyer, R. F., Tong, S., Cook, B. T., Holloway, B. P., McCaustland, K. A., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030759 · Cited by 353
Huang, C., Wen, T., Shi, F.-J., Zeng, X.-Y., & Jiao, Y.-J. (2020) · ACS Omega · doi:10.1021/acsomega.0c01554 · Cited by 350
Cardiovascular complications of severe acute respiratory syndrome
Yu, C.-M., Wong, R. S.-M., Wu, E. B., Kong, S.-L., Wong, J., Yip, G. W.-K., Soo, Y. O. Y., Chiu, M. L. S., Chan, Y.-S., Hui, D., et al. (2006) · Postgraduate Medical Journal · doi:10.1136/pgmj.2005.037515 · Cited by 345
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
Hilgenfeld, R., & Peiris, M. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.08.015 · Cited by 354
Xie, C., Jiang, L., Huang, G., Pu, H., Gong, B., Lin, H., Ma, S., Chen, X., Long, B., Si, G., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.050 · Cited by 343
SARS among Critical Care Nurses, Toronto
Loeb, M., McGeer, A., Henry, B., Ofner, M., Rose, D., Hlywka, T., Levie, J., McQueen, J., Smith, S., Moss, L., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030838 · Cited by 345
“Caused by a novel strain of coronavirus, the disease was reported in more than 8,400 people globally, with cases in Asia, Europe, and North America in 2003 (2) (3) (4) .”
BackgroundSARS‐CoV‐2 nucleocapsid protein phase‐separates with RNA and with human hnRNPs
Perdikari, T. M., Murthy, A. C., Ryan, V. H., Watters, S., Naik, M. T., & Fawzi, N. L. (2020) · The EMBO Journal · doi:10.15252/embj.2020106478 · Cited by 364
de Wilde, A. H., Raj, V. S., Oudshoorn, D., Bestebroer, T. M., van Nieuwkoop, S., Limpens, R. W. A. L., Posthuma, C. C., van der Meer, Y., Bárcena, M., Haagmans, B. L., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.052910-0 · Cited by 348
Santosh, K. C. (2020) · Journal of Medical Systems · doi:10.1007/s10916-020-01562-1 · Cited by 341
Bertram, S., Dijkman, R., Habjan, M., Heurich, A., Gierer, S., Glowacka, I., Welsch, K., Winkler, M., Schneider, H., Hofmann-Winkler, H., et al. (2013) · Journal of Virology · doi:10.1128/jvi.03372-12 · Cited by 350
Sims, A. C., Baric, R. S., Yount, B., Burkett, S. E., Collins, P. L., & Pickles, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15511-15524.2005 · Cited by 349
The severe acute respiratory syndrome coronavirus in tears
Loon, S.-C. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.035931 · Cited by 342
Nidovirus transcription: how to make sense…?
Pasternak, A. O., Spaan, W. J. M., & Snijder, E. J. (2006) · Journal of General Virology · doi:10.1099/vir.0.81611-0 · Cited by 347
Wathelet, M. G., Orr, M., Frieman, M. B., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.00702-07 · Cited by 345
Glass, W. G., Subbarao, K., Murphy, B., & Murphy, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.4030 · Cited by 340
Lian, J., Jin, X., Hao, S., Cai, H., Zhang, S., Zheng, L., Jia, H., Hu, J., Gao, J., Zhang, Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa242 · Cited by 340
Analysis of Serum Cytokines in Patients with Severe Acute Respiratory Syndrome
Zhang, Y., Li, J., Zhan, Y., Wu, L., Yu, X., Zhang, W., Ye, L., Xu, S., Sun, R., Wang, Y., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.8.4410-4415.2004 · Cited by 338
Modern Uses of Electron Microscopy for Detection of Viruses
Goldsmith, C. S., & Miller, S. E. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00027-09 · Cited by 330
The Middle East Respiratory Syndrome Coronavirus ( MERS - COV )
Jahan, F., & Al Maqbali, A. A. (2015) · World Family Medicine Journal/Middle East Journal of Family Medicine · doi:10.5742/mewfm.2015.92625 · Cited by 334
Cavanagh, D. (2003) · Avian Pathology · doi:10.1080/03079450310001621198 · Cited by 332
Pulmonary pathology of severe acute respiratory syndrome in Toronto
Hwang, D. M., Chamberlain, D. W., Poutanen, S. M., Low, D. E., Asa, S. L., & Butany, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800247 · Cited by 332
“Caused by a newly discovered SARS-associated coronavirus (SARS-CoV)”
BackgroundHuman Coronaviruses: What Do They Cause?
Van Der Hoek, L. (2007) · Antiviral Therapy · doi:10.1177/135965350701200s01.1 · Cited by 331
Holmes, K. V. (2003) · New England Journal of Medicine · doi:10.1056/nejmp030078 · Cited by 330
Fan, K., Wei, P., Feng, Q., Chen, S., Huang, C., Ma, L., Lai, B., Pei, J., Liu, Y., Chen, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310875200 · Cited by 327
COVID-19: fear appeal favoring purchase behavior towards personal protective equipment
Addo, P. C., Jiaming, F., Kulbo, N. B., & Liangqiang, L. (2020) · The Service Industries Journal · doi:10.1080/02642069.2020.1751823 · Cited by 324
Epidemiologic Clues to SARS Origin in China
Xu, R.-H., He, J.-F., Evans, M. R., Peng, G.-W., Field, H. E., Yu, D.-W., Lee, C.-K., Luo, H.-M., Lin, W.-S., Lin, P., et al. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1006.030852 · Cited by 332
Chiu, S. S., Hung Chan, K., Wing Chu, K., Kwan, S. W., Guan, Y., Man Poon, L. L., & Peiris, J. S. M. (2005) · Clinical Infectious Diseases · doi:10.1086/430301 · Cited by 325
El Asnaoui, K., Chawki, Y., & Idri, A. (2021) · Studies in Big Data · doi:10.1007/978-3-030-74575-2_14 · Cited by 289
Design and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities
Biot, C., Daher, W., Chavain, N., Fandeur, T., Khalife, J., Dive, D., & De Clercq, E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0601856 · Cited by 320
Characterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome
Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S., Liu, J., Luo, W., Chen, T., Qin, Q., & Deng, P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-857oc · Cited by 323
Lu, W., Zheng, B.-J., Xu, K., Schwarz, W., Du, L., Wong, C. K. L., Chen, J., Duan, S., Deubel, V., & Sun, B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605402103 · Cited by 321
Transmission dynamics and evolutionary history of 2019‐nCoV
Li, X., Wang, W., Zhao, X., Zai, J., Zhao, Q., Li, Y., & Chaillon, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25701 · Cited by 321
Molecular pathology of emerging coronavirus infections
Gralinski, L. E., & Baric, R. S. (2015) · The Journal of Pathology · doi:10.1002/path.4454 · Cited by 319
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection
Matsuyama, S., Ujike, M., Morikawa, S., Tashiro, M., & Taguchi, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503203102 · Cited by 315
Detection of SARS Coronavirus in Patients with Suspected SARS
Chan, K. H., Poon, L. L. L. M., Cheng, V. C. C., Guan, Y., Hung, I. F. N., Kong, J., Yam, L. Y. C., Seto, W. H., Yuen, K. Y., & Peiris, J. S. M. (2004) · Emerging Infectious Diseases · doi:10.3201/eid1002.030610 · Cited by 314
Jaume, M., Yip, M. S., Cheung, C. Y., Leung, H. L., Li, P. H., Kien, F., Dutry, I., Callendret, B., Escriou, N., Altmeyer, R., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00671-11 · Cited by 314
Self-citationCoronavirus 2019-nCoV: A brief perspective from the front line
Han, Q., Lin, Q., Jin, S., & You, L. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.02.010 · Cited by 308
Survival of Severe Acute Respiratory Syndrome Coronavirus
Lai, M. Y. Y., Cheng, P. K. C., & Lim, W. W. L. (2005) · Clinical Infectious Diseases · doi:10.1086/433186 · Cited by 313
Castaño-Rodriguez, C., Honrubia, J. M., Gutiérrez-Álvarez, J., DeDiego, M. L., Nieto-Torres, J. L., Jimenez-Guardeño, J. M., Regla-Nava, J. A., Fernandez-Delgado, R., Verdia-Báguena, C., Queralt-Martín, M., et al. (2018) · mBio · doi:10.1128/mbio.02325-17 · Cited by 313
Metadata
- Authors
- Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., Berger, A., Burguière, A.-M., Cinatl, J., Eickmann, M., Escriou, N., Grywna, K., Kramme, S., Manuguerra, J.-C., Müller, S., Rickerts, V., Stürmer, M., Vieth, S., Klenk, H.-D., Osterhaus, A. D. M. E., Schmitz, H., & Doerr, H. W.
- Affiliations
- Goethe University Frankfurt (DE)
- From the Bernhard Nocht Institute for Tropical Medicine, National Reference Center for Tropical Infectious Diseases, Hamburg (C.D., S.G., M.P., K.G., S.K., S.M., S.V., H.S.); the Institute of Medical Virology (W.P., H.R., A.B., J.C., M.S., H.W.D.) and the Medical Clinic III (H.-R.B., V.R.), Johann Wolfgang Goethe University, Frankfurt am Main; and the Institute of Virology, Philipps University, Marburg (S.B., L.K., M.E., H.-D.K.) — all in Germany; the Pasteur Institute, Molecular Genetics of Respiratory...
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-05-15
- Volume
- 348
- Issue
- 20
- Pages
- 1967-1976
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2132260239
- Semantic Scholar
- 79116f5bb552a1a23de85d03899ab0b3763c81ee
- Cited by
- 4,574
- References
- 10
- Citations by year
- 2026: 40 · 2025: 91 · 2024: 141 · 2023: 193 · 2022: 361 · 2021: 646 · 2020: 913 · 2019: 50 · 2018: 45 · 2017: 49 · 2016: 60 · 2015: 65 · 2014: 91 · 2013: 83 · 2012: 93
- FWCI
- 222.93
- Type
- journal article
- Language
- en
- Open access
- green
- pure.eur.nl
- Licence
- other-oa
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS, novel coronavirus, SARS-CoV, virus identification, viral RNA detection, seroconversion, fecal viral shedding, plasma viral RNA
- MeSH terms
- Adult, Amino Acid Sequence, Animals, Base Sequence, Cattle, Disease Outbreaks, DNA, Viral, Female, Humans, Male, Molecular Sequence Data, Phylogeny, RNA, Viral, Sequence Homology, Nucleic Acid, Sputum, Polymerase Chain Reaction, Coronavirus, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.